AbizMind

INO has more than Covid going for it!

Long
AbizMind Updated   
NASDAQ:INO   Inovio Pharmaceuticals, Inc.
Hello all! I will like to disclose that I have been an early investor in INO since 2008! So unlike a lot of others that are new to Inovio, I really know this company well. Do not listen to CITRON as they are speaking from ignorance and not knowing anything at all about what a company like INO does or is about. \
That been said... I have been keeping a close watch on develop.60ments from INO, they have a whole lot going for them. What people don't realize is that to run such an innovative company it requires burning through a lot of cash. They have nothing out in the market right now but a whole lot already in the pipeline. I really do believe INO is one positive result news away from getting to new highs. We are looking at $15 here if we can break and get outta that zone it be off to new highs. I believe we would have already hit new highs if not for the timing of that horrible Citron research article.
Strong support around the $8 area but I don't feel like we will go that low. If we do I would accumulate even more there.

To me, no other vaccine company has more upside than INO. Keep in mind this is all speculative and nothing is guaranteed.
Nothing looks shaky about INO in fact I would argue that it has been holding up very well even with the FUDI am looking at $15.60 area as the next area we need to break and stay above to continue to get to new highs.

The truth is I can't and no one can give you a target for INO.

Trade wisely my friends
Comment:
We reached our target but due to the current global financial situation. Most markets are being pulled down. INO is still holding up well. There is a possibility of more price falling if the markets continue to move down so keep that in mind. If INO should release some good news it could start moving up again but I don't expect news on the Vaccine until June.
Trade wisely!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.